AzTrials
AzTrials

Minority StressMSTNCT06614868

Minority Stress Counseling for LGBTQ+ Individuals

A study testing Acceptance and Commitment Therapy and Treatment as Usual (TAU) in people with Minority Stress, run by University of Alabama at Birmingham at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Lesbian, gay, bisexual, transgender, and queer+ (LGBTQ+) individuals experience a breadth of mental health disparities. Reducing these disparities is an area of key psychological research. Minority stress is theorized to be an underlying source of the disparities (Meyer, 2003). Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Minority Stress
What is being tested?
Acceptance and Commitment Therapy and Treatment as Usual (TAU)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteUnited States
Study dates
15 Jan 2025to 15 Aug 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Must identify as non-heterosexual

Who cannot join

  • Suicide attempt within the past 12 months.
  • Current eating disorder.
  • Narcotics use within the past 3 months
  • Non-suicidal self-injury within the past 6 months.
  • Current/History of psychosis

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Nicholas Borgogna (Assistant Professor), PhD contact

7579693677

borgogna@uab.edu

United States1 site, 1 recruiting
  • University of Alabama at Birmingham

    Birmingham, Alabama, 35294

    Nicholas Borgogna, PhD, 435258961, borgogna@uab.edu

    Nicholas Borgogna

    Recruiting

Other trials in United States

About this study

Lesbian, gay, bisexual, transgender, and queer+ (LGBTQ+) individuals experience a breadth of mental health disparities. Reducing these disparities is an area of key psychological research. Minority stress is theorized to be an underlying source of the disparities (Meyer, 2003). Minority stress can be conceptualized as the internalized stigma that results from experiences of social marginalization. By reducing minority stress, it is hypothesized that generalized mental illness indicators might be reduced and indicators of wellbeing increased.

Read the detailed description

Adult participants will respond to advertisements by emailing a research assistant.

A research assistant will then arrange for a pre-screening interview to ensure inclusion criteria are met.

A research assistant will review informed consent and receive a signed informed consent during the pre-screening.

Participants who are accepted into the study will then be offered up to 12 sessions of ACT or receive an unstructured treatment as usual counseling condition delivered by graduate students in the UAB medical/clinical psychology program under the supervision of Dr. Borgogna. These sessions will be 45 minutes each and delivered in Dr. Borgogna's lab. During the first sessions a survey battery will be administered on a lab secure computer administered via Qualtrics. It will be re-administered at session six, and during the last session.

The survey will include a broad base of demographic, mental health, and minority stress measures.

Participants will be assigned a random number that will link their survey responses across sessions. Identifying information will not be gathered as part of data collection.

Conditions
Minority Stress
Being tested
Acceptance and Commitment Therapy, Treatment as Usual (TAU)
Keywords
Minority Stress, Acceptance and Commitment Therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Acceptance and Commitment TherapyBehavioural

    Up to 16 session of unstructured counseling therapy informed by Acceptance and Commitment Therapy tradition.

  • Treatment as Usual (TAU)Behavioural

    Unstructured counseling

Study groups in NCT06614868
Study groupRoleWhat they receive
Treatment GroupExperimentalParticipants receiving acceptance and commitment therapy
Receives: Behavioral: Acceptance and Commitment Therapy
Treatment as usualActive comparatorUnstructured counseling intervention
Receives: Behavioral: Treatment as Usual (TAU)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depression

    Patient Health Questionnaire-9

    Measured: 12 weeks

  2. Anxiety

    Generalized Anxiety Disorder-7

    Measured: 12 Weeks

  3. Post Traumatic Stress

    Patient Checklist-5

    Measured: 12 Weeks

  4. Internalized Heterosexism

    Internalized Homophobia Scale

    Measured: 12 Weeks

  5. Discrimination

    Daily Heterosexist Questionnaire

    Measured: 12 Weeks

  6. Alcohol Problems

    Alcohol Use Disorders Identification Test

    Measured: 16 Weeks

Secondary outcomes (4)
  1. Experiential Avoidance

    Experiential Avoidance Rating Scale

    Measured: 16 Weeks

  2. Affect

    Positive Negative Affect Schedule

    Measured: 16 Weeks

  3. Problematic Pornography Use

    Brief Pornography Screen

    Measured: 12 Weeks

  4. Life Quality

    Quality of Life Scale

    Measured: 12 Weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Sep 2024
  2. Study start15 Jan 2025
  3. Primary completion1 Aug 2027 (estimated)
  4. Study completion15 Aug 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized control trial
Masking
Single blind
Who is masked
Participant
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06614868
Sponsor's protocol ID
IRB-300013570
Other IDs
NBLAB1
Acronym
MST
Status last verified
Aug 2026
First submitted
24 Sep 2024
Last updated
31 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: deidentified data will be shared upon request

Questions about this trial

What is this clinical trial studying?

A study testing Acceptance and Commitment Therapy and Treatment as Usual (TAU) in people with Minority Stress, run by University of Alabama at Birmingham at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 31 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nicholas Borgogna (Assistant Professor), PhD (7579693677, borgogna@uab.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depression (time frame: 12 weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in